Clinical benefit of Prostaglandin E1-treatment of patients with ischemic heart disease: stimulation of therapeutic angiogenesis in vital and infarcted myocardium

This publication has 23 references indexed in Scilit:

• Clinical and experimental evidence of prostaglandin E1-induced angiogenesis in the myocardium of patients with ischemic heart disease
  Cardiovascular Research, 2002
• Infarct scar as living tissue
  Basic Research in Cardiology, 2002
• Angiogenesis stimulation in explanted hearts from patients pre-treated with intravenous prostaglandin E1
  The Journal of Heart and Lung Transplantation, 2001
• Infarct scar: a dynamic tissue
  Cardiovascular Research, 2000
• The infarcted myocardium Simply dead tissue, or a lively target for therapeutic interventions
  Cardiovascular Research, 1999
• Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine
  The Journal of Heart and Lung Transplantation, 1999
• Effects of Prostaglandin E1, Dobutamine and Placebo on Hemodynamic, Renal and Neurohumoral Variables in Patients with Advanced Heart Failure.
  Japanese Heart Journal, 1999
• Prostaglandin E1--bridge to cardiac transplantation: Technique, dosage, results
  European Heart Journal, 1997
• Structural basis of end-stage failure in ischemic cardiomyopathy in humans.
  Circulation, 1994
• Remodeling and reparation of the cardiovascular system
  Journal of the American College of Cardiology, 1992